NASDAQ: KLTOKlotho Neurosciences Inc Stock
$0.54+0.02 (+3.85%)
Updated Oct 3, 2024
KLTO Price
$0.54
Fair Value Price
N/A
Market Cap
$9.29M
52 Week Low
$0.51
52 Week High
$13.10
P/E
N/A
P/B
-5.99x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$2.80M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-3.13
Operating Cash Flow
-$514k
Beta
0.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
KLTO Overview
Redwoods Acquisition Corporation is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or other similar combinations with one or more businesses. In intends to target the carbon neutral and energy storage industries. Redwoods Acquisition was incorporated in 2021 and is headquartered in New York, NY.
Zen Score
–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KLTO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KLTO's cash and short-term investments ($845.34k) can cover KLTO's cash burn for the next year (N/A), after accounting for decreasing cash burn (N/A)
Interest Coverage Financials
KLTO's short-term assets ($999.84k) exceed its short-term liabilities ($898.56k)
Short-term Liabilities Financials
KLTO's long-term liabilities ($3.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more KLTO due diligence checks available for Premium users.
Be the first to know about important KLTO news, forecast changes, insider trades & much more!
KLTO News
Valuation
KLTO fair value
Fair Value of KLTO stock based on Discounted Cash Flow (DCF)
Price
$0.54
Fair Value
-$0.15
Undervalued by
467.74%
KLTO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
-109.51x
Market
26.22x
KLTO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-5.99x
Industry
5.92x
KLTO's financial health
Profit margin
Revenue
$0.0
Net Income
-$451.6k
Profit Margin
0%
KLTO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$3.3M
Liabilities
$4.9M
Debt to equity
-3.13
KLTO's short-term assets ($999.84k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KLTO's long-term liabilities ($3.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KLTO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
KLTO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$907.4k
Investing
-$1.0
Financing
$1.7M
KLTO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KLTO vs Biotech Stocks
Klotho Neurosciences Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.